Results 101 to 110 of about 24,144 (221)
International Forum of Allergy &Rhinology, Volume 16, Issue 8, Page 886-888, August 2026.
Alessia Giorli +9 more
wiley +1 more source
ABSTRACT Background Although particulate matter is an environmental factor that may increase the risk of developing chronic rhinosinusitis (CRS), the impact of pollen on CRS outcomes is understudied. Here, we analyzed the effects of preoperative pollen exposure on disease‐specific and general quality‐of‐life (QOL) outcomes after endoscopic sinus ...
Benton Tullis +9 more
wiley +1 more source
We report a case of severe asthma with chronic rhinosinusitis with nasal polyps and eosinophilic otitis media that was successfully controlled by switching biologic therapy from dupilumab to mepolizumab. Careful monitoring of disease activity and consideration of biologic switching may help achieve optimal control with currently available biologics ...
Tomoko Tajiri +5 more
wiley +1 more source
This study established clinical cohorts of respiratory viral infections and identified sphinganine‐phosphate (SA) as a metabolite significantly upregulated post‐infection through metabolomic analysis. In vitro and in vivo experiments demonstrated that SA promotes the generation of effector CD8+ T cells via the SOCS1/JAK1/STAT1 pathway, which ...
Zhongwen Hu +10 more
wiley +1 more source
Microsurgical treatment of cerebrospinal fluid rhinorrhea
Cerebrospinal fluid (CSF) rhinorrhea is frequently seen in diseases involved in the skull base area, especially common in the cranio-cerebral trauma accompaniedwith skull base fracture.
CUI Jing-yu +4 more
doaj
Integrated Clinical Trial and Molecular Profiling Reveals Immune Drivers of Chronic Hand Eczema
This study performed an unbiased molecular profiling of CHE patients across diverse etiologies to identify shared pathogenic drivers and evaluate the impact of IL‐4Rα blockade via dupilumab over 16 weeks. CHE shows a mixed immune signature involving type 1, 2, and 3 pathways with features of atopic dermatitis and psoriasis.
Perrine Gery +25 more
wiley +1 more source
3 years follow‐up study to a DBPC dose‐finding trial investigating subcutaneous immunotherapy with T502 in birch‐pollen induced allergic rhinoconjunctivitis. 154 birch‐pollen allergic adults received short‐course treatment of 10,000 mTU/mL of T502 for 2 years and were observed during the next season without treatment.
Ralph Mösges +15 more
wiley +1 more source
Visual function and cerebrospinal fluid volume along the optic nerve in patients with spontaneous cerebrospinal fluid rhinorrhea: a cross-sectional study. [PDF]
Zhang Z +5 more
europepmc +1 more source
Cystic Clival Chordoma Presenting With Cerebrospinal Fluid Rhinorrhea: A Case Report and Literature Review. [PDF]
Mochizuki Y +5 more
europepmc +1 more source
Spontaneous Cerebrospinal Fluid Rhinorrhea in an Otherwise Healthy 42-Year-Old Female Presenting to a Resident Clinic. [PDF]
Antes AW, Nguyen NV, White KC.
europepmc +1 more source

